Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000453
CNY
6.95
0.09 (1.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROCE of 3.19%

  • The company has been able to generate a Return on Capital Employed (avg) of 3.19% signifying low profitability per unit of total capital (equity and debt)
2

Poor long term growth as Net Sales has grown by an annual rate of 0.43% and Operating profit at -1.21% over the last 5 years

 
3

Negative results in Mar 25

4

With ROE of 2.67%, it has a attractive valuation with a 1.32 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 3,053 Million (Small Cap)

stock-summary
P/E

50.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.35%

stock-summary
Debt Equity

-0.21

stock-summary
Return on Equity

2.67%

stock-summary
Price to Book

1.32

Revenue and Profits:
Net Sales:
476 Million
(Quarterly Results - Jun 2025)
Net Profit:
19 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.27%
0%
6.27%
6 Months
4.67%
0%
4.67%
1 Year
-7.7%
0%
-7.7%
2 Years
-20.21%
0%
-20.21%
3 Years
-29.58%
0%
-29.58%
4 Years
31.13%
0%
31.13%
5 Years
31.88%
0%
31.88%

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.43%
EBIT Growth (5y)
-1.21%
EBIT to Interest (avg)
-11.55
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.84
Tax Ratio
25.83%
Dividend Payout Ratio
112.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.19%
ROE (avg)
1.97%
Valuation key factors
Factor
Value
P/E Ratio
50
Industry P/E
Price to Book Value
1.32
EV to EBIT
28.54
EV to EBITDA
14.89
EV to Capital Employed
1.41
EV to Sales
1.37
PEG Ratio
NA
Dividend Yield
2.35%
ROCE (Latest)
4.93%
ROE (Latest)
2.67%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1.06% vs -2.04% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 19.11% vs 115.07% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "475.70",
          "val2": "470.70",
          "chgp": "1.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "45.80",
          "val2": "43.10",
          "chgp": "6.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "2.50",
          "chgp": "4.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.20",
          "chgp": "-150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "18.70",
          "val2": "15.70",
          "chgp": "19.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.90%",
          "val2": "44.70%",
          "chgp": "0.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -12.54% vs -2.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.38% vs 20.70% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,021.90",
          "val2": "2,311.90",
          "chgp": "-12.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "186.50",
          "val2": "232.50",
          "chgp": "-19.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.30",
          "val2": "16.10",
          "chgp": "-11.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.10",
          "val2": "-54.30",
          "chgp": "94.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "66.10",
          "val2": "58.30",
          "chgp": "13.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "46.40%",
          "val2": "60.10%",
          "chgp": "-1.37%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
475.70
470.70
1.06%
Operating Profit (PBDIT) excl Other Income
45.80
43.10
6.26%
Interest
2.60
2.50
4.00%
Exceptional Items
-0.10
0.20
-150.00%
Consolidate Net Profit
18.70
15.70
19.11%
Operating Profit Margin (Excl OI)
49.90%
44.70%
0.52%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.06% vs -2.04% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 19.11% vs 115.07% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,021.90
2,311.90
-12.54%
Operating Profit (PBDIT) excl Other Income
186.50
232.50
-19.78%
Interest
14.30
16.10
-11.18%
Exceptional Items
-3.10
-54.30
94.29%
Consolidate Net Profit
66.10
58.30
13.38%
Operating Profit Margin (Excl OI)
46.40%
60.10%
-1.37%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -12.54% vs -2.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 13.38% vs 20.70% in Dec 2023

stock-summaryCompany CV
About Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. stock-summary
stock-summary
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available